In contrast, the percentage of Gli1- and Gli2-positive cells in Melan-A-positive tumor cells was significantly decreased in the GANT61-treated group compared to the control group (Gli1: Figure 3D, p < 0.05, Gli2: Figure 3E, p < 0.05). This evidence concerns the gene GLI1 and neoplasm.